Table 6.
EAA levels in VA-ECMO patients with a proven infection within 96 h.
| No. | Type | Microorganisms | Day | EAA | |||
|---|---|---|---|---|---|---|---|
| T1 | T2 | T3 | T4 | ||||
| 4 | Bacteremia | Actinomyces odontolyticus | 0 | 0.38 | 0.35 | 0.59 | 0.49 |
| 10 | Pneumonia | Klebsiella pneumoniae | 1 | 0.47 | 0.57 | 0.47 | 0.52 |
| 14 | Bacteremia | Klebsiella pneumoniae | 0 | - | 0.57 | 0.76 | 0.61 |
| 26 | Pneumonia | Klebsiella pneumoniae | 0 | 0.17 | 0.38 | 0.52 | 0.56 |
| 31 | Pneumonia | Stenotrophomonas maltophilia | 3 | 0.49 | 0.35 | 0.61 | 0.5 |
| 37 | Pneumonia | Klebsiella pneumoniae | 0 | 0.26 | 0.52 | 0.9 | 0.59 |
| 44 | Pneumonia | Acinetobacter nosocomialis | 4 | 0.17 | 0.14 | 0.38 | 0.29 |
| 45 | Pneumonia | Klebsiella pneumoniae | 4 | 0.13 | 0.81 | 0.24 | 0.32 |
| 46 | Pneumonia | Klebsiella pneumoniae | 0 | 0.5 | 0.11 | 0.05 | - |
| 47 | Pneumonia | Elizabethkingia meningoseptica | 3 | 0.21 | 0.39 | 0.16 | 0.29 |
| 48 | Pneumonia | Pseudomonas aeruginosa | 4 | 0.4 | 0.35 | 0.4 | - |
| 51 | Pneumonia | Klebsiella pneumoniae | 0 | - | 0.36 | 0.28 | 0.32 |
Four study time points: within 24 h (T1) and 25–48 (T2), 49–72 (T3), and 73–96 h (T4) after ECMO initiation. EAA, endotoxin activity assay.